You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 23, 2025

Drugs Containing Excipient (Inactive Ingredient) PECTIN


✉ Email this page to a colleague

« Back to Dashboard


Branded drugs containing PECTIN excipient, and estimated key patent expiration / generic entry dates

CompanyTradenameIngredientNDCExcipientPotential Generic Entry
E-Z-EM Canada Inc E-Z-PAQUE barium sulfate 32909-750 PECTIN
Archimedes Pharma US Inc LAZANDA fentanyl citrate 51772-311 PECTIN
West Therapeutic Development LLC LAZANDA fentanyl 71500-140 PECTIN
>Company>Tradename>Ingredient>NDC>Excipient>Potential Generic Entry
Showing 1 to 3 of 3 entries

Market Dynamics and Financial Trajectory for the Pharmaceutical Excipient: Pectin

Introduction to Pectin

Pectin, a complex polysaccharide found in the cell walls of plants, particularly in the skin and core of apples and the white path of citrus fruits, has been a versatile ingredient in various industries, including food, cosmetics, and pharmaceuticals. Its unique properties make it an essential component in multiple applications.

Global Pectin Market Overview

The global pectin market is projected to grow significantly over the coming years. As of 2024, the market size is estimated to be around USD 1.01 billion and is expected to reach USD 1.35 billion by 2029, growing at a Compound Annual Growth Rate (CAGR) of 6.02% during the forecast period[1].

Key Applications of Pectin

Food and Beverage Industry

Pectin is widely used in the food and beverage sector as a thickener, stabilizer, and gelling agent. Products such as jams, jellies, and marmalades are major application areas. The increasing demand for plant-based and vegan products is driving the growth of pectin in this sector, especially in regions like Europe where the sales value of plant-based food is on the rise[1].

Pharmaceutical Industry

In the pharmaceutical sector, pectin and its derivatives are gaining prominence due to their exceptional physicochemical and biological properties. They are used in drug delivery systems, particularly for targeted drug delivery, and have shown potential in treating various conditions such as cancer, inflammation, pain, Alzheimer's, and bacterial infections. Pectin's biocompatibility and ability to provide regulated release make it a viable candidate for medicinal applications[3].

Cosmetics and Personal Care

Pectin is also used in the cosmetics and personal care industry. For instance, GENU Pectin by CP Kelco is used as a nature-based skin feel aid, stabilizer, and pH-balancing ingredient, highlighting the diverse applications of pectin beyond food and pharmaceuticals[1].

Regional Market Dynamics

Europe

Europe holds the largest market share in the pectin market, driven by the high demand from end-use applications. The region's strong food and beverage industry, along with a growing vegan population, contributes significantly to the market growth[1].

Asia Pacific

The Asia Pacific region is the fastest-growing market for pectin, driven by emerging economies such as China and India. The increasing production of processed and convenience foods in these countries is expected to drive the demand for pectin in the coming years[5].

North America

North America is another significant market for pectin, with the U.S. being a key player. The region's pharmaceutical excipients market, which includes pectin, is expected to grow substantially, with a CAGR of 6.31% from 2024 to 2033[4].

Market Concentration and Key Players

The global pectin market is highly competitive, with international players dominating the market. Key players include Cargill Incorporated, Royal DSM, Herbstreith and Fox Corporate Group, International Flavors & Fragrances, and JM Huber Corporation. These companies are focusing on developing new and innovative products, increasing production capacities, and investing in R&D activities to stay competitive[1].

Price Trends and Supply Chain

Recent forecasts indicate a positive price trend for pectin, particularly in the U.S. market. This increase is attributed to supply chain disruptions, heightened demand, and fluctuations in raw material costs. The food and beverage industry is devising strategies to absorb or pass on these increased costs to consumers[2].

Pharmaceutical Excipients Market Context

The global pharmaceutical excipients market, which includes pectin, is projected to grow from USD 8.37 billion in 2023 to USD 14.72 billion by 2033, with a CAGR of 5.81% from 2024 to 2033. In North America, the pharmaceutical excipients market is expected to reach USD 5.66 billion by 2033, registering a CAGR of 6.04% from 2024 to 2033. Pectin's role in this market is significant due to its use in drug delivery systems and other pharmaceutical applications[4].

Future Outlook

The future of the pectin market looks promising, driven by its diverse applications and growing demand. Here are some key points to consider:

  • Increasing Demand for Plant-Based Products: The growing vegan population and demand for plant-based foods are expected to drive the market growth in regions like Europe and emerging economies in Asia Pacific[1][5].
  • Technological Advancements: Continuous R&D and technological advancements are expected to lead to the development of new and innovative pectin products, further expanding its application areas[1].
  • Pharmaceutical Applications: Pectin's potential in pharmaceutical applications, particularly in drug delivery systems, is expected to contribute significantly to the market growth[3].

Key Takeaways

  • The global pectin market is expected to reach USD 1.35 billion by 2029, growing at a CAGR of 6.02% from 2024 to 2029.
  • Europe holds the largest market share, followed by North America, with the Asia Pacific region being the fastest-growing market.
  • Pectin has diverse applications in the food, pharmaceutical, and cosmetics industries.
  • Key players are focusing on R&D and increasing production capacities to meet the growing demand.
  • The pharmaceutical excipients market, which includes pectin, is projected to grow significantly over the next decade.

FAQs

What is the current market size of the pectin market?

The pectin market size is expected to reach USD 1.01 billion in 2024[1].

Which region holds the largest market share in the pectin market?

Europe holds the largest market share in the pectin market[1].

What are the primary applications of pectin?

Pectin is primarily used in the food and beverage industry as a thickener and stabilizer, and in the pharmaceutical industry for drug delivery systems[1][3].

Who are the key players in the pectin market?

Key players include Cargill Incorporated, Royal DSM, Herbstreith and Fox Corporate Group, International Flavors & Fragrances, and JM Huber Corporation[1].

What is the expected CAGR of the pectin market from 2024 to 2029?

The pectin market is expected to grow at a CAGR of 6.02% from 2024 to 2029[1].

Sources

  1. Mordor Intelligence: Pectin Market Report | Industry Analysis, Size & Forecast Overview
  2. ChemAnalyst: November 2023 Forecasts a Positive Price Trend for Pectin in the US Market
  3. PubMed: Pharmaceutical and drug delivery applications of pectin and its nanocomposites
  4. BioSpace: Pharmaceutical Excipients Market Size USD 14.72 Billion by 2033 and CAGR 5.81 Percent
  5. MarketsandMarkets: Pectin Market Insights, Trends | Global Industry Report, 2025

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.